In compliance with Regulation 29 of SEBI (Substantial Acquisition of Shares and Takeover) Regulations, 2011, please find enclosed herewith disclosure received from Trident Texofab Limited ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Trident Lifeline Ltd has submitted to BSE a disclosure it received from Trident Texofab Limited under SEBI's Substantial Acquisition of Shares and Takeover Regulations, 2011. Regulation 29 disclosures are triggered when a shareholder crosses certain ownership thresholds or makes changes to their shareholding. Trident Lifeline is acting as a conduit, passing along another entity's compliance filing to the stock exchange. No transaction details, share quantities, or price figures are visible in this filing.
This is a procedural compliance filing rather than a corporate action, so direct impact on Trident Lifeline shareholders is limited. The underlying disclosure from Trident Texofab Limited may be more meaningful and could indicate a change in promoter or major shareholder holdings, which investors should review separately for any price or governance implications.